{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T21:15:41Z","timestamp":1773436541892,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Dry eye disease (also called keratoconjunctivitis sicca) is a common condition, with a prevalence ranging from 8\u201334%, depending on the criteria used.<jats:sup>1<\/jats:sup> It becomes more common with increasing age and affects more women than men. Artificial tears and ocular lubricants are considered the mainstay of treatment and there is a very wide range of these products available. In England in 2014, over 6.4 million prescription items for artificial tears, ocular lubricants and astringents were dispensed in the community at a cost to the NHS of over \u00a327 million.<jats:sup>2<\/jats:sup> In this article we review the management of dry eye disease, focusing on artificial tears and ocular lubricants.<\/jats:p>","DOI":"10.1136\/dtb.2016.1.0378","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T07:05:18Z","timestamp":1452668718000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["The management of dry eye"],"prefix":"10.1136","volume":"54","member":"239","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"2025082700292969000_54.1.9.1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"2025082700292969000_54.1.9.2","unstructured":"Health and Social Care Information Centre, 2015. Prescription cost analysis, England-2014 [online]. Available: http:\/\/www.hscic.gov.uk\/catalogue\/PUB17274 [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2014.02.002"},{"key":"2025082700292969000_54.1.9.4","doi-asserted-by":"crossref","unstructured":"Dry Eye Workshop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surf 2007; 5: 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"2025082700292969000_54.1.9.5","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ophtha.2010.12.016","article-title":"Treatment of Sj\u00f6grens syndrome-associated dry eye","volume":"118","author":"Akpek","year":"2011","journal-title":"Ophthalmology"},{"key":"2025082700292969000_54.1.9.6","doi-asserted-by":"crossref","unstructured":"Kastelan S , et al . Diagnostic procedures and management of dry eye. Biomed Res Int 2013: 309723.","DOI":"10.1155\/2013\/309723"},{"key":"2025082700292969000_54.1.9.7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305201"},{"key":"2025082700292969000_54.1.9.8","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304619"},{"issue":"(suppl 1)","key":"2025082700292969000_54.1.9.9","first-page":"4","article-title":"Screening, diagnosis and management of dry eye disease: practical guidelines for Canadian optometrists","volume":"76","author":"Prokopich","year":"2015","journal-title":"Can J Optometry"},{"key":"2025082700292969000_54.1.9.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2013.11.002"},{"key":"2025082700292969000_54.1.9.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2009.00683.x"},{"key":"2025082700292969000_54.1.9.12","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.5.615"},{"key":"2025082700292969000_54.1.9.13","unstructured":"National Institute for Health and Care Excellence, 2012. Clinical Knowledge Summaries: Dry eye syndrome [online]. Available: http:\/\/cks.nice.org.uk\/dry-eye-syndrome [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.14","unstructured":"Medicines and Healthcare products Regulatory Agency, 2013. Borderlines between medical devices and medicinal products [online]. Available: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/284493\/Borderlines_between_medical_devices_and_medicinal_products.pdf [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.15","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2020.03.0023"},{"key":"2025082700292969000_54.1.9.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2013.02.002"},{"key":"2025082700292969000_54.1.9.17","unstructured":"Moorfields Eye Hospital NHS Foundation Trust, 2015. GP Handbook - common eye condition management [online]. Available: http:\/\/www.moorfields.nhs.uk\/content\/gp-handbook [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.18","unstructured":"Henderson R , Madden L . Dry-eye management. Optometry 2013; 14: 137\u201346."},{"key":"2025082700292969000_54.1.9.19","unstructured":"American Academy of Ophthalmology, 2013. Preferred practice pattern\u2014Dry eye syndrome [online]. Available: http:\/\/www.aao.org\/preferred-practice-pattern\/dry-eye-syndrome-ppp-2013 [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.20","unstructured":"Great Western Hospitals NHS Foundation Trust, 2015. Prescribing guidelines for dry eye syndrome-3Ts formulary [online]. Available: http:\/\/www.gwh.nhs.uk\/media\/157031\/prescribing_guidance_on_dry_eye_syndrome_final_oct13.pdf [Accessed 16 December 2015]"},{"key":"2025082700292969000_54.1.9.21","unstructured":"Northampton General Hospital NHS Trust, 2015. Formulary chapter 11\u2014eye [online]. Available: http:\/\/www.northamptonformulary.nhs.uk\/chaptersSubDetails.asp?FormularySectionID=11&SubSectionRef=11.08.01&SubSectionID=A100 [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.22","unstructured":"Rotherham Clinical Commissioning Group, 2013. Ocular lubricant prescribing guidelines [online]. http:\/\/www.rotherham.nhs.uk\/files\/Medicines%20Management\/Guidelines\/NHSR%20Ocular%20lubricants%20Prescribing%20Guidelines%201%205%202013%20V%205%20Jan14.pdf [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.23","unstructured":"Surrey, North East Hampshire, Farnham CCG, Crawley CCG, Horsham, Mid-Sussex CCG, 2014. Prescribing guidelines for dry eye management [online]. Available: http:\/\/www.surreyandsussex.nhs.uk\/wp-content\/uploads\/2013\/04\/Surrey-PCN-Dry-Eyes-Management1.pdf [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.24","unstructured":"Moorfields Eye Hospital NHS Foundation Trust, 2015. Ophthalmic formulary [online]. Available: http:\/\/www.moorfields.nhs.uk\/sites\/default\/files\/uploads\/documents\/Ophthalmic%20Formulary%20v1.13%20November%202015.pdf [Accessed 16 December 2015]"},{"key":"2025082700292969000_54.1.9.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.optm.2009.02.010"},{"key":"2025082700292969000_54.1.9.26","unstructured":"Ikervis 1\u2005mg\/mL eye drops, emulsion. Summary of product characteristics, EU.\u00a0Santen Oy, June 2015."},{"key":"2025082700292969000_54.1.9.27","unstructured":"Scottish Medicines Consortium, 2015. Ciclosporin (Ikervis) [online]. Available: https:\/\/www.scottishmedicines.org.uk\/SMC_Advice\/Advice\/1089_15_ciclosporin_Ikervis\/ciclosporin_Ikervis [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.28","unstructured":"National Institute for Health and Care Excellence, 2015. Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears [online]. Available: https:\/\/www.nice.org.uk\/guidance\/TA369 [Accessed 16 December 2015]."},{"key":"2025082700292969000_54.1.9.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2599-1"},{"key":"2025082700292969000_54.1.9.30","doi-asserted-by":"publisher","DOI":"10.1159\/000131090"},{"key":"2025082700292969000_54.1.9.31","doi-asserted-by":"publisher","DOI":"10.1111\/nure.12145"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2016.1.0378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:29:39Z","timestamp":1756279779000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2016.1.0378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,13]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/dtb.2016.1.0378"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2016.1.0378","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}